Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05493_nanopub.RAp3NEISalZ-HEz-El7MCmGfAusl41bU4f_wSxhXoTcJg#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05493 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05493 label "NX-1207 [drugbank:DB05493]" assertion.
- drugbank:DB05493 seeAlso DB05493 assertion.
- drugbank:DB05493 description "NX-1207 is an investigational new drug for BPH, whose chemical entity and mechanism of action remain undisclosed. Nymox Pharmaceutical Corporation recently completed studies of NX-1207 for treatment of benign prostatic hyperplasia (BPH)." assertion.
- drugbank:DB05493 identifier "drugbank:DB05493" assertion.
- drugbank:DB05493 title "NX-1207" assertion.
- drugbank:DB05493 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05493 drugbank_vocabulary:drugbank-id "DB05493" assertion.
- drugbank:DB05493 bio2rdf_vocabulary:x-identifiers.org DB05493 assertion.
- drugbank:DB05493 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05493" assertion.
- drugbank:DB05493 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05493 bio2rdf_vocabulary:identifier "DB05493" assertion.